ArticleBMC cancer2017

HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.

Martin McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.